*NEW EUROPEAN CASE DEFINITION OF EBOLA MAKES OVERREPORTING OF EBOLA VERY HARD
*RECOGNIZES RISK OF DROPLET TRANSMISSION OF EBOLA VIRUS BUT ONLY DURING ACUTE STAGE
*NEW DEFINITION REQUIRES HIGHER STANDARD OF PERSONAL PROTECTION EQUIPMENT THAN CDC
*DANGER STILL REMAINS BECAUSE EMERGENCY USE GSK AND NIH EBOLA JAB COULD INJECT EBOLA STRAIGHT INTO BLOOD STREAM
The European Centre of Disease Control (ECDC) has tightened its case definition of Ebola and also said that only lab confirmed cases of Ebola are to be reported at the European level, thereby making it more difficult for WHO, the CDC and the media to manipulate figures and hype an Ebola epidemic in Europe.
The change in European Ebola reporting criteria comes as it emerges that 69% of the Ebola cases reported in Liberia by WHO have not been lab confirmed through blood tests. A massive overestimation of Ebola cases by WHO by misclassifying malaria and cholera and other diseases has, therefore, highly likely occurred.
As happened during the swine flu pandemic of 2009, WHO and the CDC appear to be engaged in the brazen manipulation of data to justify mass vaccination with untested drug.
The ECDC has also tightened its case definition of Ebola ensuring a higher standard of personal protection equipment is needed by medical personnel including respirators.
It recognizes droplet transmission of Ebola but only in the acute stage.
“With the added proviso that the suspected or confirmed Ebola patient in question is `coughing, vomiting, bleeding, or who had diarrhoea’ – being within 1 meter of an EVD patient is considered to have a High Risk of exposure by the ECDC; essentially recognizing the risks of droplet transmission of the virus.”
A flu diary blogspot has offered a comparison of the CDC and ECDC Ebola case definition criteria.
Ebola patients in the CDC criteria do not have to present any Ebola symptoms or be in an acute phase of the disease to be classified as high risk.
Ebola is only contagious in the acute phase when patients present with distinct symptoms.
While the ECDC changes are welcome because they make Ebola hype harder, we are not out of the woods yet.
It cannot be ruled out that the experimental GSK and NIH Ebola vaccine will result in the Ebola virus being injected straight into people’s blood stream. This can happen off stage, for example, in homeless shelters in Europe (some funded in Greece by George Soros) and the USA.